Anyang-si, South Korea

Jeong-Ho Joo



Average Co-Inventor Count = 7.3

ph-index = 4

Forward Citations = 33(Granted Patents)


Location History:

  • Seoul, KR (1999 - 2000)
  • Kyungki-do, KR (2003 - 2006)
  • Anyang-si, KR (2010)

Company Filing History:


Years Active: 1999-2010

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Jeong-Ho Joo

Introduction

Jeong-Ho Joo is a notable inventor based in Anyang-si, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antiviral agents. With a total of 6 patents to his name, Joo's work has the potential to impact the treatment of serious viral infections.

Latest Patents

Among his latest patents, Joo has developed a method for the use of pyrimidinedione derivatives in preventing or treating hepatitis C. This invention highlights a pyrimidinedione derivative that exhibits excellent inhibitory activity against the hepatitis C virus. Additionally, he has patented antiviral pyrimidinedione derivatives and the processes for their preparation. These derivatives are particularly useful as agents for the treatment of AIDS, showcasing a wide range of potential applications in antiviral therapy.

Career Highlights

Jeong-Ho Joo has worked with reputable companies such as Samjin Pharmaceutical Co., Ltd. and Samjin Pharm. Co., Ltd. His experience in these organizations has allowed him to refine his skills and contribute to significant advancements in pharmaceutical research and development.

Collaborations

Throughout his career, Joo has collaborated with esteemed colleagues, including Eui-Hwan Cho and Sun-Gan Chung. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Jeong-Ho Joo's contributions to the field of pharmaceuticals through his innovative patents and collaborations demonstrate his commitment to advancing medical science. His work continues to pave the way for new treatments that could benefit many patients worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…